BR0112690A - Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos - Google Patents
Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativosInfo
- Publication number
- BR0112690A BR0112690A BR0112690-3A BR0112690A BR0112690A BR 0112690 A BR0112690 A BR 0112690A BR 0112690 A BR0112690 A BR 0112690A BR 0112690 A BR0112690 A BR 0112690A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- cilansetron
- constipative
- ibs patients
- containing drug
- Prior art date
Links
- NCNFDKWULDWJDS-OAHLLOKOSA-N cilansetron Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C=3N4CCCC=3C=CC=2)=C4CC1 NCNFDKWULDWJDS-OAHLLOKOSA-N 0.000 title abstract 3
- 229960002099 cilansetron Drugs 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 229940126601 medicinal product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10036645 | 2000-07-26 | ||
| DE10123447A DE10123447A1 (de) | 2000-07-26 | 2001-05-14 | Cilansetron enthaltende Arzneimittel zur Behandlung nicht-obstipativer männlicher IBS-Patienten |
| PCT/EP2001/008260 WO2002007713A2 (de) | 2000-07-26 | 2001-07-18 | Cilansetron enthaltende arzneimittel zur behandlung nicht-obstipativer männlicher ibs-patienten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0112690A true BR0112690A (pt) | 2003-06-24 |
Family
ID=26006529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0112690-3A BR0112690A (pt) | 2000-07-26 | 2001-07-18 | Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1307195A2 (ru) |
| JP (1) | JP2004504343A (ru) |
| CN (1) | CN1444479A (ru) |
| AR (1) | AR028970A1 (ru) |
| AU (1) | AU2001276409A1 (ru) |
| BR (1) | BR0112690A (ru) |
| CA (1) | CA2417677A1 (ru) |
| CZ (1) | CZ2003158A3 (ru) |
| HU (1) | HUP0301479A2 (ru) |
| IL (1) | IL153972A0 (ru) |
| MX (1) | MXPA02012917A (ru) |
| NO (1) | NO20030373D0 (ru) |
| PL (1) | PL363517A1 (ru) |
| RU (1) | RU2003104798A (ru) |
| SK (1) | SK1272003A3 (ru) |
| WO (1) | WO2002007713A2 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0216027D0 (en) | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
| WO2005073220A1 (ja) * | 2004-01-30 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | 下痢型過敏性腸症候群治療剤 |
| NZ541656A (en) * | 2004-01-30 | 2008-05-30 | Astellas Pharma Inc | The use of ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome |
| JP4632204B2 (ja) * | 2005-09-21 | 2011-02-16 | アステラス製薬株式会社 | 下痢型過敏性腸症候群治療剤 |
| US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| US7601856B2 (en) | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
| GB9930077D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
-
2001
- 2001-06-21 AR ARP010102958A patent/AR028970A1/es unknown
- 2001-07-18 EP EP01954044A patent/EP1307195A2/de not_active Withdrawn
- 2001-07-18 SK SK127-2003A patent/SK1272003A3/sk unknown
- 2001-07-18 JP JP2002513449A patent/JP2004504343A/ja active Pending
- 2001-07-18 HU HU0301479A patent/HUP0301479A2/hu unknown
- 2001-07-18 RU RU2003104798/15A patent/RU2003104798A/ru not_active Application Discontinuation
- 2001-07-18 BR BR0112690-3A patent/BR0112690A/pt not_active Application Discontinuation
- 2001-07-18 CA CA002417677A patent/CA2417677A1/en not_active Abandoned
- 2001-07-18 CZ CZ2003158A patent/CZ2003158A3/cs unknown
- 2001-07-18 IL IL15397201A patent/IL153972A0/xx unknown
- 2001-07-18 AU AU2001276409A patent/AU2001276409A1/en not_active Abandoned
- 2001-07-18 MX MXPA02012917A patent/MXPA02012917A/es unknown
- 2001-07-18 CN CN01813307A patent/CN1444479A/zh active Pending
- 2001-07-18 WO PCT/EP2001/008260 patent/WO2002007713A2/de not_active Application Discontinuation
- 2001-07-18 PL PL01363517A patent/PL363517A1/xx not_active Application Discontinuation
-
2003
- 2003-01-24 NO NO20030373A patent/NO20030373D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002007713A2 (de) | 2002-01-31 |
| MXPA02012917A (es) | 2003-05-14 |
| IL153972A0 (en) | 2003-07-31 |
| EP1307195A2 (de) | 2003-05-07 |
| PL363517A1 (en) | 2004-11-29 |
| HUP0301479A2 (hu) | 2003-09-29 |
| AR028970A1 (es) | 2003-05-28 |
| WO2002007713A3 (de) | 2002-11-14 |
| NO20030373L (no) | 2003-01-24 |
| AU2001276409A1 (en) | 2002-02-05 |
| JP2004504343A (ja) | 2004-02-12 |
| SK1272003A3 (en) | 2003-07-01 |
| RU2003104798A (ru) | 2004-06-27 |
| CN1444479A (zh) | 2003-09-24 |
| NO20030373D0 (no) | 2003-01-24 |
| CZ2003158A3 (cs) | 2003-08-13 |
| CA2417677A1 (en) | 2003-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR020662A1 (es) | Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento. | |
| BR0112591A (pt) | Derivados de acridina e sua aplicação como medicamento | |
| BR0112044A (pt) | Embalagem de produtos medicinais para terapia de erradicação | |
| NO20031018D0 (no) | Oksymorfonpreparater med kontrollert frigivelse | |
| BR0112589A (pt) | Derivados de heteroarila e sua aplicação como medicamento | |
| NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
| IL149147A0 (en) | Use of oxcarbazepine for the manufacture of oral dosage form medicament | |
| MX9207495A (es) | Compuestos de tetrahidroisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| DE60034240D1 (de) | Drogen zur behandlung maligner tumoren | |
| BR0114344A (pt) | Retinóides para o tratamento de enfisema | |
| DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
| TR200101633T2 (tr) | Farmasötik bileşim | |
| AR035889A1 (es) | Citrato de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9- pentaeno y composiciones farmaceuticas que la contienen y su uso para la elaboracion de medicamentos | |
| BR0112807A (pt) | Derivados de indol e sua aplicação como medicamento | |
| ATE360428T1 (de) | Analgetisches arzneimittel | |
| BR0112690A (pt) | Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos | |
| EE200200088A (et) | Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks | |
| BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos | |
| HUP0200145A2 (hu) | Tianeptin alkalmazása neurodegeneratív betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| SE0004827D0 (sv) | Therapeutic compounds | |
| CY1106964T1 (el) | Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους | |
| ES2170649A1 (es) | Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica. | |
| AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
| PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |